Swiss pharmaceutical giant Novartis (NVS) on Friday reported forecast-beating quarterly sales as its clutch of heart failure to breast cancer ...

NASA is set to collaborate with SpaceX to return astronauts from the ISS amidst plans for further cosmic exploration. Samples ...

If we're being frank, which is how we roll in the Rocket Report, some of Orbex's recent activity does not inspire confidence.

Wing Commander Shubhanshu Shukla and Indian Air Force IAF officer who was recently chosen as the Prime astronaut for Indian Space Research Organisation I ...

In the previous Budget, finance minister Nirmala Sitharaman announced an impressive allocation of INR 1,000 crore, giving the ...

India is becoming the world's go-to launch pad with a record number of foreign satellites being launched from the country in ...

In January, the GSLV-F15 mission will carry the NVS-02 navigation satellite to enhance the NavIC constellation, incorporating domestically developed atomic clocks to improve India’s navigation and ...

Although the revenue and EPS for Novartis (NVS) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall ...

Ionis Pharmaceuticals (IONS) stock slips as Novartis (NVS) delays Phase 3 trial data for its cardiac therapy pelacarsen. Read more here.

Swiss pharmaceutical giant Novartis on Friday reported fourth-quarter results after repeatedly raising its full-year guidance ...

Jefferies analyst Peter Welford maintained a Hold rating on Novartis AG (NOVN – Research Report) today and set a price target of ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...